|
US2490813A
(en)
|
1944-11-29 |
1949-12-13 |
Standard Oil Co |
Continuous process for making aryl amines
|
|
US3299078A
(en)
|
1962-10-01 |
1967-01-17 |
Smith Kline French Lab |
Pyrido [3', 4': 4, 5] pyrrolo [3, 2, 1-hi] indoles and-[3, 2, 1-ij] quinolines
|
|
US3813392A
(en)
|
1969-06-09 |
1974-05-28 |
J Sellstedt |
Pyrrolo(1,2,3-alpha epsilon)quinoxalin-2(3h)-ones and related compounds
|
|
US4115577A
(en)
|
1972-06-19 |
1978-09-19 |
Endo Laboratories, Inc. |
Pyridopyrrolobenzheterocycles
|
|
US4238607A
(en)
|
1972-06-19 |
1980-12-09 |
Endo Laboratories Inc. |
Pyridopyrrolo benzheterocycles
|
|
US3914421A
(en)
|
1972-06-19 |
1975-10-21 |
Endo Lab |
Pyridopyrrolobenzheterocycles for combatting depression
|
|
US4183936A
(en)
|
1972-06-19 |
1980-01-15 |
Endo Laboratories, Inc. |
Pyridopyrrolobenzheterocycles
|
|
US4001263A
(en)
|
1974-04-01 |
1977-01-04 |
Pfizer Inc. |
5-Aryl-1,2,3,4-tetrahydro-γ-carbolines
|
|
IE41352B1
(en)
|
1974-04-01 |
1979-12-19 |
Pfizer |
5-aryl-1,2,3,4-tetrahydro- -carbolines
|
|
US4136145A
(en)
|
1974-07-05 |
1979-01-23 |
Schering Aktiengesellschaft |
Medicament carriers in the form of film having active substance incorporated therein
|
|
US4219550A
(en)
|
1978-11-09 |
1980-08-26 |
E. I. Du Pont De Nemours And Company |
Cis- and trans- octahydropyridopyrrolobenzheterocycles
|
|
US4389330A
(en)
|
1980-10-06 |
1983-06-21 |
Stolle Research And Development Corporation |
Microencapsulation process
|
|
IE52535B1
(en)
|
1981-02-16 |
1987-12-09 |
Ici Plc |
Continuous release pharmaceutical compositions
|
|
US4530840A
(en)
|
1982-07-29 |
1985-07-23 |
The Stolle Research And Development Corporation |
Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents
|
|
US4522944A
(en)
|
1982-12-23 |
1985-06-11 |
Erba Farmitalia |
Carboxamido-derivatives of 5H-1,3,4-thiadiazolo[3,2-a]pyrimidines, compositions and use
|
|
CH656884A5
(de)
|
1983-08-26 |
1986-07-31 |
Sandoz Ag |
Polyolester, deren herstellung und verwendung.
|
|
EP0219762B1
(de)
|
1985-10-09 |
1990-12-27 |
Desitin Arzneimittel GmbH |
Verfahren zur Herstellung einer Darreichungs- und Dosierungsform für Arzneimittel-Wirkstoffe, Reagentien oder andere Wirkstoffe
|
|
ATE90683T1
(de)
|
1986-03-19 |
1993-07-15 |
Kumiai Chemical Industry Co |
5h-1,3,4-thiazol(3,2-a>pyrimidin-5-on-derivate und diese enthaltende fungizide zubereitungen.
|
|
EP0242690B1
(en)
|
1986-04-07 |
1993-06-30 |
Kumiai Chemical Industry Co., Ltd. |
5H-1,3,4-Thiadiazolo[3,2-a]pyrimidin-5-one derivatives and agricultural-horticultural fungicide composition containing the same
|
|
HU208484B
(en)
|
1988-08-17 |
1993-11-29 |
Chinoin Gyogyszer Es Vegyeszet |
Process for producing pharmaceutical composition containing acid additional salt of selegilin as active component for treating schisofrenia
|
|
US5114976A
(en)
|
1989-01-06 |
1992-05-19 |
Norden Michael J |
Method for treating certain psychiatric disorders and certain psychiatric symptoms
|
|
US5538739A
(en)
|
1989-07-07 |
1996-07-23 |
Sandoz Ltd. |
Sustained release formulations of water soluble peptides
|
|
DE4018247A1
(de)
|
1990-06-07 |
1991-12-12 |
Lohmann Therapie Syst Lts |
Herstellungsverfahren fuer schnellzerfallende folienfoermige darreichungsformen
|
|
IT1271352B
(it)
|
1993-04-08 |
1997-05-27 |
Boehringer Ingelheim Italia |
Derivati dell'indolo utili nel trattamento dei disturbi del sistema nervoso centrale
|
|
ATE288270T1
(de)
|
1993-11-19 |
2005-02-15 |
Janssen Pharmaceutica Nv |
Mikroverkapselte 1,2-benzazole
|
|
CN1079670C
(zh)
|
1994-03-02 |
2002-02-27 |
阿克佐诺贝尔公司 |
舌下或颊给药的药物组合物
|
|
US6221335B1
(en)
|
1994-03-25 |
2001-04-24 |
Isotechnika, Inc. |
Method of using deuterated calcium channel blockers
|
|
CN1087725C
(zh)
|
1994-03-25 |
2002-07-17 |
同位素技术有限公司 |
用氘代方法增强药物效果
|
|
US5576460A
(en)
|
1994-07-27 |
1996-11-19 |
Massachusetts Institute Of Technology |
Preparation of arylamines
|
|
US5654482A
(en)
|
1996-02-29 |
1997-08-05 |
Xerox Corporation |
Triarylamine processes
|
|
US5648542A
(en)
|
1996-02-29 |
1997-07-15 |
Xerox Corporation |
Arylamine processes
|
|
US5648539A
(en)
|
1996-02-29 |
1997-07-15 |
Xerox Corporation |
Low temperature arylamine processes
|
|
US5847166A
(en)
|
1996-10-10 |
1998-12-08 |
Massachusetts Institute Of Technology |
Synthesis of aryl ethers
|
|
DE19646392A1
(de)
|
1996-11-11 |
1998-05-14 |
Lohmann Therapie Syst Lts |
Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
|
|
US5723671A
(en)
|
1997-01-30 |
1998-03-03 |
Xerox Corporation |
Arylamine processes
|
|
US5705697A
(en)
|
1997-01-30 |
1998-01-06 |
Xerox Corporation |
Arylamine processes
|
|
US5723669A
(en)
|
1997-01-30 |
1998-03-03 |
Xerox Corporation |
Arylamine processes
|
|
TWI242011B
(en)
|
1997-03-31 |
2005-10-21 |
Eisai Co Ltd |
1,4-substituted cyclic amine derivatives
|
|
US6323366B1
(en)
|
1997-07-29 |
2001-11-27 |
Massachusetts Institute Of Technology |
Arylamine synthesis
|
|
GB2328686B
(en)
|
1997-08-25 |
2001-09-26 |
Sankio Chemical Co Ltd |
Method for producing arylamine
|
|
US6884429B2
(en)
|
1997-09-05 |
2005-04-26 |
Isotechnika International Inc. |
Medical devices incorporating deuterated rapamycin for controlled delivery thereof
|
|
US6395939B1
(en)
|
1997-10-06 |
2002-05-28 |
Massachusetts Institute Of Technology |
Diaryl ether condensation reactions
|
|
EP1058678B1
(en)
|
1998-02-26 |
2002-12-11 |
Massachusetts Institute of Technology |
Metal-catalyzed arylations and vinylations of hydrazines, hydrazones, hydroxylamines and oximes
|
|
US6235936B1
(en)
|
1998-02-26 |
2001-05-22 |
Massachusetts Institute Of Technology |
Metal-catalyzed arylations of hydrazines, hydrazones, and related substrates
|
|
US5902901A
(en)
|
1998-05-07 |
1999-05-11 |
Xerox Corporation |
Arylamine processes
|
|
ATE360634T1
(de)
|
1998-07-10 |
2007-05-15 |
Massachusetts Inst Technology |
Ligande für metalle und verbesserte metall- katalysierte verfahren, die darauf basieren
|
|
US6307087B1
(en)
|
1998-07-10 |
2001-10-23 |
Massachusetts Institute Of Technology |
Ligands for metals and improved metal-catalyzed processes based thereon
|
|
US7223879B2
(en)
|
1998-07-10 |
2007-05-29 |
Massachusetts Institute Of Technology |
Ligands for metals and improved metal-catalyzed processes based thereon
|
|
US6395916B1
(en)
|
1998-07-10 |
2002-05-28 |
Massachusetts Institute Of Technology |
Ligands for metals and improved metal-catalyzed processes based thereon
|
|
TW550080B
(en)
|
1998-11-17 |
2003-09-01 |
Shionogi & Co |
Transdermic preparation comprising cerebral function activating agent
|
|
US20010008942A1
(en)
|
1998-12-08 |
2001-07-19 |
Buchwald Stephen L. |
Synthesis of aryl ethers
|
|
US6440710B1
(en)
|
1998-12-10 |
2002-08-27 |
The Scripps Research Institute |
Antibody-catalyzed deuteration, tritiation, dedeuteration or detritiation of carbonyl compounds
|
|
AU765909C
(en)
|
1998-12-17 |
2004-09-23 |
Alza Corporation |
Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings
|
|
US6552024B1
(en)
|
1999-01-21 |
2003-04-22 |
Lavipharm Laboratories Inc. |
Compositions and methods for mucosal delivery
|
|
NO309305B1
(no)
|
1999-02-19 |
2001-01-15 |
Norsk Hydro As |
Anvendelse av benzaldehydderivater ved fremstilling av farmasöytiske preparater for forebygging og/eller behandling av kreft, samt visse nye benzaldehydderivater
|
|
PE20010052A1
(es)
|
1999-04-23 |
2001-01-27 |
Upjohn Co |
Compuestos de azepinindol tetraciclico como agonistas o antagonistas del receptor de 5-ht
|
|
US6407092B1
(en)
|
1999-04-23 |
2002-06-18 |
Pharmacia & Upjohn Company |
Tetracyclic azepinoindole compounds
|
|
US6713471B1
(en)
|
1999-06-15 |
2004-03-30 |
Bristol-Myers Squibb Pharma Company |
Substituted heterocycle fused gamma-carbolines
|
|
AR024378A1
(es)
|
1999-06-15 |
2002-10-02 |
Du Pont Pharm Co |
Gamma-carbolinas fusionadas heterociclicas sustituidas
|
|
US7071186B2
(en)
|
1999-06-15 |
2006-07-04 |
Bristol-Myers Squibb Pharma Co. |
Substituted heterocycle fused gamma-carbolines
|
|
DK1104760T3
(da)
|
1999-12-03 |
2003-06-30 |
Pfizer Prod Inc |
Sulfamoylheteroarylpyrazolforbindelser som anti-inflammatoriske/analgetiske midler
|
|
US6541639B2
(en)
|
2000-07-26 |
2003-04-01 |
Bristol-Myers Squibb Pharma Company |
Efficient ligand-mediated Ullmann coupling of anilines and azoles
|
|
WO2002011768A1
(en)
*
|
2000-08-03 |
2002-02-14 |
Antares Pharma Ipl Ag |
Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
|
|
JP2004509894A
(ja)
|
2000-09-20 |
2004-04-02 |
ファルマシア・アンド・アップジョン・カンパニー |
置換アゼピノ［４，５−ｂ］インドリン誘導体
|
|
US6849619B2
(en)
|
2000-12-20 |
2005-02-01 |
Bristol-Myers Squibb Company |
Substituted pyridoindoles as serotonin agonists and antagonists
|
|
KR20030070073A
(ko)
|
2000-12-20 |
2003-08-27 |
브리스톨-마이어스스퀴브컴파니 |
세로토닌 효능제 및 길항제로서의 치환된 피리도인돌
|
|
CN1266112C
(zh)
|
2001-04-24 |
2006-07-26 |
麻省理工学院 |
铜－催化的碳－杂原子键和碳－碳键的形成
|
|
DE10123129A1
(de)
|
2001-05-02 |
2002-11-14 |
Berolina Drug Dev Ab Svedala |
Deuterierte 3-Piperidinopropiophenone sowie diese Verbindungen enthaltende Arzneimittel
|
|
MXPA03011784A
(es)
|
2001-06-22 |
2004-04-02 |
Pfizer Prod Inc |
Composiciones farmaceuticas de dispersiones de farmacos y polimeros neutros.
|
|
WO2003014118A1
(en)
|
2001-08-08 |
2003-02-20 |
Pharmacia & Upjohn Company |
THERAPEUTIC 1H-PYRIDO[4,3-b]INDOLES
|
|
US8900498B2
(en)
|
2001-10-12 |
2014-12-02 |
Monosol Rx, Llc |
Process for manufacturing a resulting multi-layer pharmaceutical film
|
|
US7357891B2
(en)
|
2001-10-12 |
2008-04-15 |
Monosol Rx, Llc |
Process for making an ingestible film
|
|
US8603514B2
(en)
|
2002-04-11 |
2013-12-10 |
Monosol Rx, Llc |
Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
|
|
US8900497B2
(en)
|
2001-10-12 |
2014-12-02 |
Monosol Rx, Llc |
Process for making a film having a substantially uniform distribution of components
|
|
US20070281003A1
(en)
|
2001-10-12 |
2007-12-06 |
Fuisz Richard C |
Polymer-Based Films and Drug Delivery Systems Made Therefrom
|
|
EP1314554A1
(fr)
|
2001-11-23 |
2003-05-28 |
Kba-Giori S.A. |
Dispositif de décollage d'éléments de sécurité
|
|
DE10162121A1
(de)
|
2001-12-12 |
2003-06-18 |
Berolina Drug Dev Ab Svedala |
Deuterierte substituierte Pyrazolyl-Benzolsulfonamide sowie diese Verbindungen enthaltende Arzneimittel
|
|
RU2321391C2
(ru)
|
2002-07-29 |
2008-04-10 |
Алза Корпорейшн |
Способы и лекарственные формы для контролируемой доставки палиперидона
|
|
US20050232995A1
(en)
|
2002-07-29 |
2005-10-20 |
Yam Nyomi V |
Methods and dosage forms for controlled delivery of paliperidone and risperidone
|
|
CN1684944A
(zh)
|
2002-08-02 |
2005-10-19 |
麻省理工学院 |
铜催化形成碳－杂原子和碳－碳键的方法
|
|
US7223870B2
(en)
|
2002-11-01 |
2007-05-29 |
Pfizer Inc. |
Methods for preparing N-arylated oxazolidinones via a copper catalyzed cross coupling reaction
|
|
WO2004041281A1
(en)
|
2002-11-01 |
2004-05-21 |
Oregon Health And Science University |
Treatment of hyperkinetic movement disorder with donepezil
|
|
TW200413273A
(en)
|
2002-11-15 |
2004-08-01 |
Wako Pure Chem Ind Ltd |
Heavy hydrogenation method of heterocyclic rings
|
|
ES2364046T3
(es)
|
2002-12-19 |
2011-08-23 |
Bristol-Myers Squibb Company |
Gamma-carbolinas tricíclicas sustituidas utilizadas como agonistas y antagonistas de los receptores de la serotonina.
|
|
CA2512639C
(en)
|
2003-01-16 |
2012-10-30 |
Acadia Pharmaceuticals Inc. |
Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases
|
|
KR20060037391A
(ko)
|
2003-07-21 |
2006-05-03 |
스미스클라인 비참 코포레이션 |
(2Ｓ,4Ｓ)-4-플루오로-1-[4-플루오로-베타-(4-플루오로페닐)-Ｌ-페닐알라닐]-2-피롤리딘카르보니트릴 ｐ-톨루엔설폰산염 및 이의 무수 결정 형태
|
|
US7244734B2
(en)
|
2003-09-26 |
2007-07-17 |
Solvay Pharmaceuticals B.V. |
Hexa- and octahydro-pyrido[1,2-a]pyrazine derivatives with NK1 antagonistic activity
|
|
JP2005259113A
(ja)
|
2004-02-12 |
2005-09-22 |
Ricoh Co Ltd |
プロセス編集装置、プロセス管理装置、プロセス編集プログラム、プロセス管理プログラム、記録媒体、プロセス編集方法及びプロセス管理方法
|
|
WO2005095396A1
(en)
|
2004-03-05 |
2005-10-13 |
Pharma C S.A. |
8-phenoxy-ϝ carboline derivatives
|
|
US20050222209A1
(en)
|
2004-04-01 |
2005-10-06 |
Zeldis Jerome B |
Methods and compositions for the treatment, prevention or management of dysfunctional sleep and dysfunctional sleep associated with disease
|
|
US7592454B2
(en)
|
2004-04-14 |
2009-09-22 |
Bristol-Myers Squibb Company |
Substituted hexahydro-pyridoindole derivatives as serotonin receptor agonists and antagonists
|
|
WO2005118587A1
(en)
|
2004-06-02 |
2005-12-15 |
Takeda Pharmaceutical Company Limited |
Indole derivative and use for treatment of cancer
|
|
EP1787648A4
(en)
*
|
2004-09-03 |
2010-06-23 |
Dainippon Sumitomo Pharma Co |
MEDICAL COMPOSITION FOR PERCUTANEOUS PEROSPIRON MANAGEMENT
|
|
US8461148B2
(en)
|
2004-09-20 |
2013-06-11 |
Icahn School Of Medicine At Mount Sinai |
Use of memantine (namenda) to treat autism, compulsivity and impulsivity
|
|
JP2008513432A
(ja)
|
2004-09-21 |
2008-05-01 |
ファイザー・プロダクツ・インク |
Ｃｎｓ状態の治療に有用なｎ−メチルヒドロキシエチルアミン
|
|
US7614727B2
(en)
|
2004-09-30 |
2009-11-10 |
Fujifilm Corporation |
Liquid ejection head, manufacturing method thereof, and image forming apparatus
|
|
DE602005019465D1
(de)
|
2004-12-15 |
2010-04-01 |
Hoffmann La Roche |
Bi- und trizyklische substituierte phenyl-methanone als inhibitoren von glycin-i (glyt-1)-transportern zur behandlung der alzheimer-krankheit
|
|
AU2006209216A1
(en)
|
2005-01-25 |
2006-08-03 |
Galenea Corp |
Substituted arylamine compounds and their use as 5-HT6 modulators
|
|
CA2595711A1
(en)
|
2005-01-25 |
2006-08-03 |
Celgene Corporation |
Methods and compositions using 4-amino-2-(3-methyl-2,6-dioxopiperidin-3-yl)-isoindole-1-3-dione
|
|
US7598273B2
(en)
|
2005-10-06 |
2009-10-06 |
Auspex Pharmaceuticals, Inc |
Inhibitors of the gastric H+, K+-ATPase with enhanced therapeutic properties
|
|
BRPI0706523A2
(pt)
|
2006-01-13 |
2011-01-04 |
Wyeth Corp |
composto de fórmula i; composição farmacêutica; método de tratamento de distúrbios que estão relacionados com ou são afetados pela inibição da recaptação de norepinefrina, o receptor de 5-ht6 ou o receptor de 5-ht2a; método de tratamento de um distúrbio de aprendizado, de um distúrbio cognitivo, de um distúrbio de memória, de um distúrbio de personalidade, de um distúrbio comportamental, de um distúrbio de movimento, de um distúrbio neurodegenerativo, de abstinência de droga, de distúrbio de sono, de um distúrbio alimentar, de uma toxicidade de droga aguda, de um distúrbio cardiovascular, de uma disfunção sexual, de um distúrbio gastrintestinal, de um distúrbio genitourinário, de um distúrbio de dor, de um distúrbio nervoso ou de um distúrbio de sintoma vasomotor; método de tratamento de doença de alzheimer, de um distúrbio de deficiência da atenção, de esquizofrenia, de doença de parkinson, de discinésia tardia, de ataxia, de bradicinésia, de discinésias paroxìsmicas, de sìndrome da perna irrequieta, de tremor, de tremor essencial, de epilepsia, de apoplexia ou de trauma na cabeça; método de tratamento de doença arterial coronariana, de enfarte do miocárdio, de ataque isquêmico transitório, de angina, de fibrilação atrial, de agregação plaquetária, de risco de formação de coágulo sanguìneo, de sìndrome do intestino irritável, de constipação crÈnica, de doença do refluxo gastrintestinal, de dispepsia, de incontinência urinária por estresse ou de incontinência urinária de urgência; método de tratamento de depressão, de distúrbio compulsivo obsessivo, de tendência ao suicìdio, de distúrbio de ansiedade, de distúrbio bipolar, de distúrbio de pánico, de abstinência de nicotina, de abstinência de álcool, de abstinência de cocaìna, de abstinência de heroìna, de abstinência de anfetamina, de abstinência de drogas narcóticas, de insÈnia, de apnéia do sono, de narcolepsia, de distúrbio afetivo sanzonal, de sìndrome da perna irrequieta, de distúrbio de sono de turno de trabalho, de sìndrome da fase do sono retardada, de anorexia nervosa, de bulimia nervosa, de sìndrome do comer noturno, de superalimentação compulsiva, de sìndrome da fadiga crÈnica, de fibromialgia, de neuropatia de dor, de dor antinociceptiva, de sìndrome da dor crÈnica, de neuropatia diabética, de fogacho ou de suor noturno; e uso de um composto
|
|
US7750168B2
(en)
|
2006-02-10 |
2010-07-06 |
Sigma-Aldrich Co. |
Stabilized deuteroborane-tetrahydrofuran complex
|
|
AU2007255724B2
(en)
|
2006-06-09 |
2012-05-10 |
Dainippon Sumitomo Pharma Co., Ltd. |
Novel tape preparation
|
|
EP2068872A1
(en)
|
2006-09-08 |
2009-06-17 |
Braincells, Inc. |
Combinations containing a 4-acylaminopyridine derivative
|
|
CA2679754C
(en)
|
2007-03-12 |
2018-08-07 |
Intra-Cellular Therapies, Inc. |
Substituted heterocycle fused gamma-carbolines synthesis
|
|
CA2719824A1
(en)
|
2007-08-01 |
2009-02-05 |
Medivation Neurology, Inc. |
Methods and compositions for treating schizophrenia using antipsychotic combination therapy
|
|
AU2008282743B2
(en)
|
2007-08-02 |
2012-11-29 |
Insys Therapeutics Inc. |
Sublingual fentanyl spray
|
|
US9567327B2
(en)
|
2007-08-15 |
2017-02-14 |
Arena Pharmaceuticals, Inc. |
Imidazo[1,2-a]pyridine derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
|
|
US20090209608A1
(en)
|
2007-08-29 |
2009-08-20 |
Protia, Llc |
Deuterium-enriched asenapine
|
|
US20090076159A1
(en)
|
2007-09-19 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched eplivanserin
|
|
EP2262502A4
(en)
|
2008-02-05 |
2011-12-28 |
Clera Inc |
Compositions and methods for alleviating depression or improving cognition
|
|
JP2011511638A
(ja)
|
2008-02-07 |
2011-04-14 |
シェーリング コーポレイション |
抗ｔｓｌｐｒ抗体の設計製作
|
|
SI2262505T1
(sl)
|
2008-03-12 |
2015-03-31 |
Intra-Cellular Therapies, Inc. |
Substituirana heterociklirano zliti gama-karbolinska trdna snov
|
|
WO2009145900A1
(en)
|
2008-05-27 |
2009-12-03 |
Intra-Cellular Therapies, Inc. |
Methods and compositions for sleep disorders and other disorders
|
|
US20100159033A1
(en)
|
2008-09-29 |
2010-06-24 |
Auspex Pharmaceuticals, Inc. |
Benzisoxazole modulators of d2 receptor, and/or 5-ht2a receptor
|
|
WO2011044019A1
(en)
|
2009-10-05 |
2011-04-14 |
Bristol-Myers Squibb Company |
(R)-1-(4-(4-FLUORO-2-METHYL-1H-INDOL-5-YLOXY)-5-METHYLPYRROLO[2,1-f][1,2,4]TRIAZIN-6-YLOXY)PROPAN-2-OL METABOLITES
|
|
RU2591194C2
(ru)
|
2010-04-22 |
2016-07-10 |
Интра-Селлулар Терапиз, Инк. |
Органические соединения
|
|
EP2651357B1
(en)
|
2010-12-16 |
2020-04-01 |
Sunovion Pharmaceuticals Inc. |
Sublingual films
|
|
WO2012088038A2
(en)
|
2010-12-21 |
2012-06-28 |
Albany Molecular Research, Inc. |
Piperazinone-substituted tetrahydro-carboline mch-1 antagonists, methods of making, and uses thereof
|
|
WO2012105623A1
(ja)
*
|
2011-02-02 |
2012-08-09 |
日東電工株式会社 |
貼付製剤の製造方法
|
|
US20150004237A1
(en)
|
2012-01-09 |
2015-01-01 |
Virginia Tech Intellectual Properties, Inc. |
Cellulose derivatives for inhibiting crystallization of poorly water-soluble drugs
|
|
JP2015514135A
(ja)
|
2012-04-14 |
2015-05-18 |
イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． |
新規組成物および方法
|
|
JP2014074145A
(ja)
|
2012-10-05 |
2014-04-24 |
Olympus Corp |
セルロースナノファイバーとその製造方法、複合樹脂組成物、成形体
|
|
WO2014110322A2
(en)
|
2013-01-11 |
2014-07-17 |
Concert Pharmaceuticals, Inc. |
Substituted dioxopiperidinyl phthalimide derivatives
|
|
DK2968320T3
(da)
|
2013-03-15 |
2021-02-01 |
Intra Cellular Therapies Inc |
Organiske forbindelser
|
|
EP3043777B1
(en)
|
2013-09-10 |
2020-04-22 |
Fresh Cut Development, LLC |
Sublingual buprenorphine spray
|
|
EP3052080B1
(en)
|
2013-09-30 |
2025-06-25 |
Zoetis Services LLC |
Long-acting spiro-isoxazoline formulations
|
|
CA3148303C
(en)
|
2013-12-03 |
2024-02-27 |
Intra-Cellular Therapies, Inc. |
Heterocycle fused gamma-carboline compounds for use in treatment of bipolar disorders
|
|
CA2944755A1
(en)
|
2014-04-04 |
2015-10-08 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
CA2944512C
(en)
|
2014-04-04 |
2018-04-24 |
Intra-Cellular Therapies, Inc. |
Heterocycle fused gamma-carbolines for treatment of central nervous system disorders
|
|
US10179776B2
(en)
|
2014-06-09 |
2019-01-15 |
Intra-Cellular Therapies, Inc. |
Compounds and methods of use to treat schizophrenia
|
|
EP4512394A3
(en)
|
2015-06-03 |
2025-10-22 |
Triastek, Inc. |
Dosage forms and use thereof
|
|
WO2017117514A1
(en)
*
|
2015-12-31 |
2017-07-06 |
Tung Roger D |
Deuterated iti-007
|
|
PT3407888T
(pt)
|
2016-01-26 |
2021-03-19 |
Intra Cellular Therapies Inc |
Compostos de piridopirroloquinoxalina, suas composições e utilizações
|
|
SI3407889T1
(sl)
|
2016-03-25 |
2021-09-30 |
Intra-Cellular Therapies, Inc. |
Organske spojine in njihova uporaba v zdravljenju ali preprečevanju motenj centralnega živčnega sistema
|
|
WO2017165755A1
(en)
|
2016-03-25 |
2017-09-28 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
EP3436455A4
(en)
|
2016-03-28 |
2019-09-04 |
Intra-Cellular Therapies, Inc. |
NOVEL SALTS AND CRYSTALS
|
|
HUE057055T2
(hu)
|
2016-08-09 |
2022-04-28 |
Teva Pharmaceuticals Int Gmbh |
Lumateperon-ditozilátsó szilárd halmazállapotú formái
|
|
JP7013454B2
(ja)
*
|
2016-10-12 |
2022-02-15 |
イントラ－セルラー・セラピーズ・インコーポレイテッド |
アモルファス固体分散体
|
|
WO2018106916A1
(en)
|
2016-12-07 |
2018-06-14 |
Concert Pharmaceuticals, Inc. |
Deuterated quinoxaline compounds
|
|
IL304026B2
(en)
*
|
2017-03-24 |
2024-11-01 |
Intra Cellular Therapies Inc |
A pharmaceutical preparation containing 1-(4-fluoro-phenyl)-4-((Sa10,Rb6)-3-D2-2,2-methyl-2, 3, a10, 10, 9, b6- hexahydro-H7, H1- Pyrido[3',4',:4,5]pyrrolo[3,2,1-de]quioxalin-8-yl)-butan-1-one and its uses
|
|
EP3609501A4
(en)
|
2017-04-10 |
2020-08-19 |
Dr. Reddy's Laboratories Limited |
AMORPHIC FORM AND SOLID DISPERSIONS OF LUMATEPERONE P-TOSYLATE
|
|
WO2019002204A1
(en)
*
|
2017-06-26 |
2019-01-03 |
Lts Lohmann Therapie-Systeme Ag |
TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING ASENAPINE AND SILICONE-TYPE ACRYLIC HYBRID POLYMER
|
|
US11655251B2
(en)
|
2017-11-27 |
2023-05-23 |
Egis Gyogyszergyar Zrt. |
Method for the production of lumateperone and its salts
|